Catalyst Wire Dossier Catalyst Wire Dossier

Treme

tremelimumab · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Treme, covering 2025-05-01 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer [Phase 2]

See pricing